Diabetic Footwear Market Size, Share & Industry Analysis, By Product Category (Diabetic Shoes, Diabetic Sandals, Diabetic Slippers, Diabetic Boots, and Others), By Construction Type (Prefabricated/Extra-Depth Footwear and Custom-Molded/Custom-Made Footwear), By Consumer Group (Men, Women, and Children), By Distribution Channel (Medical, Orthopedic & Diabetic Footwear Specialty Stores, Footwear & Other Specialty Retail Stores, Drugstores & Pharmacies, Online Retail, and Others), and Regional Forecast, 2026-2034

The global diabetic footwear market size was valued at USD 5.92 billion in 2025. The market is projected to grow from USD 6.27 billion in 2026 to USD 10.50 billion by 2034, exhibiting a CAGR of 6.66% during the forecast period.

The diabetic footwear industry across the globe is experiencing consistent growth due to the increasing prevalence of diabetes, the risk of developing diabetic neuropathy and other foot complications, and increased knowledge of foot care prevention measures. The demand for extra-depth shoes, molded shoes, cushioned sandals, and slippers that help reduce the risk of foot injuries is rising. Aging and an increased focus on mobility and comfortable footwear are further leading to the expansion of the customer base. Growth is also being facilitated by prescriptions from physicians, reimbursement in developed countries, and availability through specialty medical stores and online retail channels. Furthermore, advancements in technology have resulted in the production of lighter-weight shoes, better cushioning, easy-to-adjust closure systems, more sizes, and improved design.

Orthofeet, Inc., Aetrex, Inc., Orthotic Holdings, Inc., Podartis S.r.l., and Propét Footwear, Inc. are some of the leading firms operating in the market. The key strategy being used by the above-mentioned firms in their business operations includes constant innovation of their therapeutic products, which is focused mainly on providing shoes with an extra-deep design, pressure-relief footwear cushioning, wide toe box, seam-free lining, and orthotic friendly, comfortable to wear products.

DIABETIC FOOTWEAR MARKET TRENDS

Therapeutic Comfort Innovations to Improve Everyday Adoption

The integration of therapeutic features, aesthetics, and comfort has emerged as a key market trend. Some of the recent developments include extra-depth construction, seamless interiors, lightweight materials, enhanced cushioning and adjustable fastening systems. With more people becoming conscious about the importance of protective footwear while still maintaining the appearance of regular shoes, these advances are making the products more acceptable and potentially encouraging repeat purchases.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Diabetes Prevalence to Expand Demand for Protective Footwear

The increasing prevalence of diabetes have been one of the key factors responsible for the growth of diabetic footwear in various parts of the world. As diabetes becomes more prevalent, the number of individuals at risk of associated foot complications may also increase. This raises the need for shoes that provide comfort along with protection against excessive pressure and friction. Therefore, awareness of diabetes-related foot complications and preventive measures is encouraging consumers to use cushioned footwear and molded shoes.

MARKET RESTRAINTS

High Specialized Footwear Costs Limit Wider Consumer Adoption

The relatively higher pricing of specialized diabetic footwear is considered a barrier to the growth of the market due to its impact on purchasing decisions of buyers in price-sensitive markets and markets with limited incomes. The increased costs of manufacturing due to extra-depth design, cushioning, special fitting, and medical footwear materials make specialized diabetic footwear more expensive than conventional footwear. This is hindering the diabetic footwear market growth.

MARKET OPPORTUNITIES

Emerging Market Expansion to Unlock New Growth Potential

Increasing incidence of diabetes, better access to healthcare services, and growing awareness about the need for preventive measures to care for one’s feet are creating potential growth opportunities for diabetic footwear manufacturers. As diagnostic capabilities improve and the middle-class population expands, it is expected that consumers will be looking for footwear that can provide them with comfort and protection for their feet.

MARKET CHALLENGES

Limited Awareness and Clinical Access to Restrict Market Penetration

Lack of information about diabetic foot problems and inadequate recommendations for the use of such footwear have been identified as key barriers. Consumers, especially in developing countries, still prefer regular footwear even when they experience neuropathy, edema, or pressure ulcers. Limited access to podiatrists or trained specialists in footwear fitting leads to improper product choice. Therefore, delayed adoption, improper fitting, and limited preventive use can negatively affect market growth.

Segmentation Analysis

By Product Category

Greater Therapeutic Versatility Boosted Higher Adoption of Diabetic Shoes

By product category, the market is segmented into diabetic shoes, diabetic sandals, diabetic slippers, diabetic boots, and others.

Diabetic shoes accounted for the highest diabetic footwear market share in 2025, as they are widely used for everyday walking and mobility, pressure relief, and prevention of foot problems that result from diabetes. Their extra-depth construction, cushioning, and wide toe boxes, and ability to fit inserts make them suitable options for individuals with neuropathy, swelling, deformities, and sensitive feet. In addition, they have greater availability through specialty stores, footwear stores, and even online platforms, which contributes to higher sales volumes. As such, their versatility and everyday use continue to support their market position.

The others segment is anticipated to rise at the fastest CAGR of 7.82% over the forecast period. 

To know how our report can help streamline your business, Speak to Analyst

By Construction Type

Prefabricated/Extra-Depth Footwear Led Market Due to Lower Cost and Wider Availability

Based on construction type, the market is divided into prefabricated/extra-depth footwear and custom-molded/custom-made footwear.

The prefabricated/extra-depth footwear segment held the highest market share in 2025, owing to its relatively lower cost compared with custom-molded footwear options and the benefits that it offers. Prefabricated/extra-depth footwear is available in different sizes, widths, and depths and therefore can suit people with swollen feet, neuropathy, and sensitive feet. In addition, these products can accommodate orthotic inserts without requiring fully custom-made footwear. It is widely available via different sources including footwear outlets and online sources.

The custom-molded/custom-made footwear segment is anticipated to rise at the highest CAGR of 8.18% over the forecast period.

By Consumer Group

Higher Diabetes-Related Foot Care Needs Fueled Dominance of Men Segment

Based on consumer group, the market is divided into men, women, and children.

The men segment dominated the market in 2025, owing to the diabetes-related foot care needs among adult men. There is more demand for extra-depth shoes, walking shoes, and protective footwear suitable for everyday use, thus encouraging higher product adoption rates among men. There are also a wide variety of sizes and therapeutic features of diabetic shoes offered to men, making them more accessible.

The children segment is anticipated to rise at the fastest CAGR of 7.57% over the forecast period.

By Distribution Channel

Specialized Product Offerings and Professional Fitting Services Supported Dominance of Medical, Orthopedic & Diabetic Footwear Specialty Stores

Based on distribution channel, the market is segmented into medical, orthopedic & diabetic footwear specialty stores, footwear & other specialty retail stores, drugstores & pharmacies, online retail, and others.

The medical, orthopedic & diabetic footwear specialty stores segment held the dominant market share in 2025, since customers often require professional fitting services and assessments of appropriate shoe width and depth, and information about medical aspects of the footwear before making a purchase. These stores offer a wider selection of extra-depth footwear and custom-molded footwear compared to other retail outlets. Their relationships with podiatrists and orthotists may support prescription-based purchases.

The online retail segment is projected to grow at the fastest CAGR of 9.34% during the forecast period.

Diabetic Footwear Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, South America, the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America dominated the global market and is projected to grow at a CAGR of 3.32% during the forecast period. The region reached a valuation of USD 2.05 billion in 2025. The development of the diabetic footwear market in North America is determined by existing healthcare government insurance schemes, such as Medicare Part B, in accordance with the Therapeutic Shoe Bill (A5500 codes), reducing the out-of-pocket expenses for deep extra-depth or customized footwear. Market growth is fueled by the high incidence rates of diabetes and peripheral neuropathy within the region, among an aging population, leading to a high adoption of preventative podiatric footwear. Furthermore, the fast pace of technology adoption in the field of 3D foot scanning, custom additive manufacturing, and smart pressure sensing diabetic insoles may support adherence to prescribed footwear use.

U.S. Diabetic Footwear Market

The U.S. market, the largest within North America, reached USD 1.68 billion in 2025, accounting for roughly 28.34% of global sales. Market growth is mainly attributed to the Medicare Part B coverage program of therapeutic shoes for eligible diabetics, high utilization of podiatric footwear, and widespread adoption of 3D custom-fitted extra-depth shoes by consumers.

Europe

Europe held the second-largest market share in 2025, valued at USD 1.61 billion, accounting for 27.25% of global sales. Market growth is largely influenced by universal healthcare systems and statutory health insurance schemes in countries such as Germany, the U.K., and France that provide subsidies to medically approved orthopedic shoes. The tight EU medical device regulations (MDR 2017/745) have stringent standards for safety, pressure-relief footwear, and materials in therapeutic shoes, which increases clinical confidence and the rate of prescription. Additionally, the strong emphasis on multidisciplinary diabetic foot care that aim at foot ulcer prevention and reducing lower limb amputations has contributed to consistent demand for seamless, shear-resistant, and breathable liners.

U.K. Diabetic Footwear Market

The U.K. market reached USD 0.22 billion in 2025, representing roughly 3.79% of global revenues.

Germany Diabetic Footwear Market

The market in Germany reached USD 0.29 billion in 2025, equivalent to around 4.83% of global sales.

Asia Pacific

Asia Pacific ranked in the third position in the market globally, reaching USD 1.52 billion in 2025 and is projected to grow at a CAGR of 7.92%. Market growth is driven by the increasing prevalence of diabetes, expansion of the middle-class population, and urbanization in developing countries such as India and China. The changing emphasis in medicine from the reactive approach of treating ulcers to the prevention of diabetic foot care encourages a shift from conventional footwear to therapeutic footwear that offers shock absorption and support. Furthermore, increased disposable income enables urban consumers to buy technologically advanced orthopedic footwear and protective diabetic sandals, extra-depth sneakers, and insoles for the hot and humid environment.

Japan Diabetic Footwear Market

The Japanese market was valued at USD 0.21 billion in 2025, accounting for roughly 3.60% of global revenues. The demand for therapeutic footwear in Japan is influenced by the fast-growing aging population and insurance coverage by the National Health Insurance scheme, making the demand for lightweight and easy-to-wear therapeutic shoes very high.

China Diabetic Footwear Market

The market in China was valued at USD 0.63 billion in 2025, representing roughly 10.65% of global sales.

India Diabetic Footwear Market

The Indian market was valued at USD 0.36 billion in 2025, accounting for roughly 6.08% of global revenues.

South America and Middle East & Africa

The South America and Middle East & Africa regions is expected to witness moderate growth during the forecast period. The South American market reached USD 0.38 billion in 2025 due to increasing incidences of diabetes and health awareness initiatives in Brazil and Argentina, which increase basic demand for inexpensive, pressure-free, and additional depth shoes and sandals. In the Middle East & Africa, the UAE reached USD 0.07 billion in 2025.  

South Africa Diabetic Footwear Market

The South African market reached USD 0.08 billion in 2025, representing roughly 1.28% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Therapeutic Innovation and Omnichannel Expansion to Intensify Market Competition

The global diabetic footwear market is fragmented, with competition from both established orthopedic footwear manufacturers and companies that produce therapeutic footwear. There is a trend among major firms in the industry toward innovation, such as the design of shoes with more depth, cushioned footwear for added comfort, seamless, lightweight footwear with improved styling and fit. Manufacturers are increasing direct sales, collaborating with podiatrists and other healthcare professionals to improve access to therapeutic footwear, and extending their range of sizes and widths. Customized footwear, foot scanning technology, and premium products are becoming more important, while geographic expansion helps to increase accessibility to consumers in emerging markets.

LIST OF KEY DIABETIC FOOTWEAR COMPANIES PROFILED

• Orthofeet, Inc. (U.S.)
• Aetrex, Inc. (U.S.)
• Orthotic Holdings, Inc. (OHI) (U.S.)
• Podartis S.r.l. (Italy)
• Propét Footwear, Inc. (U.S.)
• Drew Shoe Corporation (U.S.)
• Anodyne, LLC (S.)
• San Antonio Shoe, Inc. (S.)
• Apis Footwear Company (S.)
• DARCO International, Inc. (S.)

KEY INDUSTRY DEVELOPMENTS

• May 2026: Anodyne, LLC highlighted that it had a complete line of A5500-approved therapeutic footwear, which included Gen 2 Heel Assist footwear that would make wearing more comfortable and would last throughout the day. The line of shoes is made up of footwear with added depth, wide toe box, removable insoles, cushioned and stable footwear.
• May 2026: The POD-X was introduced by Podartis S.r.l. at OTWorld 2026 held in Leipzig in connection with the internationalization strategy adopted by the company. The introduction of the therapeutic shoes took place at the convention targeting orthopedists and health care specialists. This introduced the platform for use in areas such as diabetic foot protection, pressure treatment, stability, and prevention among others. OTWorld 2026 was held from May 19–22.
• July 2025: Anodyne, LLC enhanced its therapeutic footwear portfolio by introducing new shoes with Heel Assist Step-In Technology. The new line featured both hands-free design and wide toe box construction along with added depth, support elements, and A5500 diabetic shoe approval, which assisted with the needs of diabetics and those with foot problems.
• September 2024: As a means of reinforcing their clinical involvement in diabetic foot care, Podartis S.r.l. contributed to science-based support for a scientific conference aimed at dealing with prevention and treatment of diabetic foot complications. This helped in uniting special skills and knowledge about preventive measures, including the application of proper footwear for diabetic patients.

REPORT COVERAGE

The global diabetic footwear market provides a comprehensive study of the market & forecast by all the market segments. This qualitative and quantitative report includes details on the market dynamics and trends that are expected to drive the market over the forecast period. It provides information on key aspects, including technological advancements, the regulatory environment, and product launches. It also provides information on partnerships, mergers & acquisitions, and key industry developments. Further, it presents a detailed competitive landscape, including market share and profiles of key players.

Request for Customization   to gain extensive market insights.

Report Scope and Segmentation